NewsRoom Articles - Page 90 of 596

WednesdaySep 13, 2023 4:20 am

420 with CNW — New Poll Suggests Most Ohio Voters Favor Legalizing Marijuana

Results from a recently released poll show that most of the voters in Ohio are in favor of a recreational cannabis legalization measure that is set to appear on ballots in November. The poll, which was conducted by Fallon Research, determined that 59% of voters in the state supported the measure to legalize marijuana for individuals 21 years of age and above. Of this number, 68% were Democrats while 62% were independent voters. The measure qualified for the ballot in August and has garnered support from individuals of different age groups, with the poll finding that more than 65% of…

TuesdaySep 12, 2023 4:20 pm

420 with CNW — Spokesperson Says Biden Supports Medical Marijuana as Cannabis Scheduling Review Progresses

President Joe Biden's stance on the medical use of marijuana has been unequivocal, as affirmed by the White House amid an ongoing federal review of cannabis scheduling. In a recent press briefing, Karine Jean-Pierre, White House press secretary, addressed inquiries regarding the potential ramifications of reclassifying marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA). The U.S. Department of Health and Human Services (HHS) recently recommended this reclassification to the U.S. Drug Enforcement Administration (DEA). Jean-Pierre, exercising caution, refrained from preempting the process. She emphasized, “I don't want to anticipate events; I've encountered this query previously.”…

TuesdaySep 12, 2023 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Investigational Research Programs Position the Company for Important Partnership Opportunities and Growth

Lexaria Bioscience has completed several studies that confirm and support the superiority and advantages of its patented DehydraTECH(TM) technology over traditional oral delivery methods The company recently announced results from its human oral nicotine study NIC-H22-1 comparing its DehydraTECH-nicotine pouch to world-leading brands, Zyn(R) and on!(R) Results from the study demonstrated that DehydraTECH-nicotine was statistically significantly faster in reaching Tmax than both brands Lexaria has also undertaken other investigational research programs, including the analysis and execution of hypertension, diabetes, hormone therapy, and dementia studies, which could birth excellent partnership opportunities, supporting further growth A report by Zacks Investment Research discussed…

TuesdaySep 12, 2023 4:20 am

420 with CNW — Maryland Unveils Online Portal Allowing Cannabis Social-Equity Applicants to Verify Eligibility

The state of Maryland has unveiled a new online portal that will allow marijuana social-equity applicants to verify their eligibility for social-equity licenses before they can officially submit applications later in the year. According to a recent statement from the Maryland Cannabis Administration (MCA), the state's Social-Equity Verification Portal will be open to the public beginning Sept. 8, 2023. Maryland Cannabis Administration Acting Director Will Tilburg said the goal of the verification tool is to provide people interested in social-equity status with a means of determining their eligibility before regulators officially open the application period. Like most states with legal…

MondaySep 11, 2023 4:20 pm

420 with CNW — Study Finds 90% of Illicit Marijuana Products Tainted with Pesticides

A recent investigation has revealed a significant disparity in safety standards between marijuana cultivated for Canada's legal market and that intended for the illicit market. A staggering 92% of unregulated marijuana samples were found to contain various pesticides, while this figure plummeted to a mere 6% for regulated products. The findings, published recently in the “Cannabis Research” Journal, involved scrutinizing 36 cannabis samples procured from licensed dispensaries and 24 illicit samples confiscated by regulatory agencies. The objective was to ascertain whether the products had been cultivated or had come into contact with any of the 327 diverse pesticides on record.…

MondaySep 11, 2023 4:20 am

420 with CNW — Shifting Cannabis to Schedule III May Have Major Ramifications

The U.S. Health and Human Services Department recently recommended that the federal government reclassify marijuana as a Schedule III drug. Drugs under this classification are said to have a low-moderate potential for addiction and/or abuse. These drugs can also be acquired through prescription, even though they aren’t generally available over the counter. They include ketamine, products with less than 90 mg of codeine and anabolic steroids. If the U.S. government heeds this call, there may be significant implications for a range of marijuana-related issues. For instance, marijuana businesses could claim deductions on their federal tax obligations because they wouldn’t be…

FridaySep 08, 2023 4:20 pm

420 with CNW — Program Targeting Illicit Marijuana Operations Announced in California

Officials in California have announced the launch of a program to crack down on illegal cannabis operations in the state and boost the legal market. The program will connect Attorney General Rob Tonta’s office with local authorities and support them in efforts to combat the illicit marijuana market by targeting the finances of illegal cannabis operators. Tonta said that the anti-illicit cannabis program will deal with illegal marijuana as a land use and public nuisance issue. Even though California is now home to the largest legal cannabis market on the entire globe, the state’s cannabis program has struggled to compete…

FridaySep 08, 2023 4:20 am

420 with CNW — NY Recreational Cannabis Rollout Hits Another Snag as Judge Halts Business Licensing

The rollout of recreational cannabis in New York has faced yet another hurdle as a judge from the state's Supreme Court has put a halt on all applications for business licenses to establish adult-use marijuana dispensaries. The judge cited inconsistent and unclear information from regulating officials. This recent setback adds to the challenges that have characterized the launch of legalized marijuana in New York. The issue revolves around a program called the Conditional Adult Use Retail Dispensary (CAURD), managed by the Office of Cannabis Management (OCM). When the state legalized marijuana in March 2021, lawmakers and cannabis regulators initially announced…

ThursdaySep 07, 2023 4:20 pm

420 with CNW — Planet 13 to Expand into Florida with Planned Acquisition of VidaCann

Planet 13 Holdings has announced a $48.9 million acquisition of VidaCann, a vertically integrated cannabis operator in Florida with 26 medical marijuana dispensaries. A recent news release revealed that both companies’ boards unanimously approved the total acquisition of VidaCann’s debt, cash and stock by Las Vegas-based cannabis firm Planet 13 Holdings. The membership interest purchase agreement will see Planet 13 Holdings acquire an operational greenhouse cultivation facility, an analytical and processing laboratory, and three product lines, including licensed brands Stanley Brothers, Tikun Olam and the VidaCann house brand. The state-of-the-art facility is fully operational and capable of supporting more than…

ThursdaySep 07, 2023 4:20 am

420 with CNW — Cannabis Shows Potential in Symptom Alleviation for Pediatric Cancer Patients

A recent study published in the “Cancer” Journal explores the potential advantages of utilizing cannabis for children undergoing cancer treatment, a group that contends with various symptoms resulting from the disease and its therapies. However, while promising, further exploration into appropriate dosing and safety is imperative. Advances in diagnostics, surgery and radiation have elevated survival rates among pediatric cancer patients. Nevertheless, progress brings its own set of issues, including anorexia, pain, vomiting and nausea, which prove challenging to manage. Cannabis derivatives have emerged as a strategy to alleviate these symptoms in young cancer patients. However, its safety, effectiveness and dosing…

News and publishing service for cannabis related companies

Contact us: 512.354.7000